Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy ...Middle East

SHANGHAI, Aug. 6, 2022 /PRNewswire/ -- Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for wide variety of diseases, today announced it has secured $20 million in...

Hence then, the article about epigenic therapeutics raises 20 million in series angel and pre a funding to advance next generation gene editing therapy was published today ( Sunday 07/08/2022 - 02:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy )

Also on site :

• US trade with Southeast Asia and Taiwan surging despite Trump tariffs
• Amazon Is Selling a 'Beautiful' $19 Cherry Blossom Tree Lamp That 'Looks Lovely at Night'
• Netflix Reboots Star Search: Who Won Big On Night 1? And Are You Vibing With The Judges? Grade The Premiere!